BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3165639)

  • 1. Studies of anthracycline--DNA complexes by circular dichroism.
    Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
    Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).
    Gao YG; Wang AH
    Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of phenolic ionization constants of anthracyclines with modified substitution pattern of anthraquinone chromophore.
    Razzano G; Rizzo V; Vigevani A
    Farmaco; 1990 Feb; 45(2):215-22. PubMed ID: 2133996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies on anthracycline haloderivatives.
    Facchinetti T; Geroni C; Fumagalli A; Giuliani FC
    Drugs Exp Clin Res; 1986; 12(8):657-61. PubMed ID: 3463498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between morpholinyl anthracyclines and DNA. The crystal structure of a morpholino doxorubicin bound to d(CGTACG).
    Cirilli M; Bachechi F; Ughetto G; Colonna FP; Capobianco ML
    J Mol Biol; 1993 Apr; 230(3):878-89. PubMed ID: 8478940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding characteristics of aclarubicin as compared with daunorubicin and doxorubicin.
    Ando S; Kamiya K; Yoshimura T; Tsutani H; Ueda T; Uchida M; Nakamura T; Uchino H
    Anticancer Res; 1988; 8(3):409-15. PubMed ID: 3164610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrostatic and non-electrostatic contributions to the binding free energies of anthracycline antibiotics to DNA.
    Baginski M; Fogolari F; Briggs JM
    J Mol Biol; 1997 Nov; 274(2):253-67. PubMed ID: 9398531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genotoxic and mutagenic activity of antineoplastic anthracyclines and their aglycones: study in two test-systems].
    Vasil'eva SV; Makhova EV; Efremenkova OV; Bartoshevich IuE
    Genetika; 1996 Feb; 32(2):233-9. PubMed ID: 8713623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
    Gallois L; Fiallo M; Garnier-Suillerot A
    Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
    Henry-Toulme N; Stefanska B; Borowski E; Bolard J
    Mol Pharmacol; 1988 May; 33(5):574-9. PubMed ID: 3367905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous mixing experiments allow to determine the size of binding sites for anthracyclines complexed to DNA.
    Walter A
    Biomed Biochim Acta; 1985; 44(9):1321-7. PubMed ID: 3866577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular level studies with anthracyclines.
    Eckle E; Kiefer E; Lauser G; Stezowski JJ
    Drugs Exp Clin Res; 1985; 11(3):207-17. PubMed ID: 3869806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure and activity of anthracyclines].
    Lavelle F
    Pathol Biol (Paris); 1987 Jan; 35(1):11-9. PubMed ID: 3550604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computational model for anthracycline binding to DNA: tuning groove-binding intercalators for specific sequences.
    Cashman DJ; Kellogg GE
    J Med Chem; 2004 Mar; 47(6):1360-74. PubMed ID: 14998326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the amino sugar in the DNA binding of disaccharide anthracyclines: crystal structure of the complex MAR70/d(CGATCG).
    Temperini C; Cirilli M; Aschi M; Ughetto G
    Bioorg Med Chem; 2005 Mar; 13(5):1673-9. PubMed ID: 15698785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.